Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-013561
Filing Date
2015-02-13
Accepted
2015-02-13 16:29:13
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 8104
  Complete submission text file 0001209191-15-013561.txt   9647
Mailing Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS NEW YORK NY 10036 2129978500
HESS CORP (Issuer) CIK: 0000004447 (see all company filings)

EIN.: 134921002 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2911 Petroleum Refining

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Quigley James H. (Reporting) CIK: 0001554331 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-01204 | Film No.: 15615126